Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease

Flow-mediated vasodilation (FMD) of systemic arteries, a non-invasive parameter of endothelial function, is correlated with cardiovascular risk factors. The relationship between FMD and morphologically and clinically evident coronary artery disease has not been described. This study was performed to test the hypothesis that an impairment of FMD in the brachial artery is related to the presence and/or extent and severity of coronary artery disease (CAD). We examined 74 patients with angina pectoris and 14 control subjects (age 17–36 years). Angiography revealed coronary artery disease (≥30% diameter stenosis) in 44 patients (CAD, age 32–67 years) and smooth coronary arteries in 30 patients (non-CAD, age 22–73 years). Vasodilation following reactive hyperemia and after sublingual nitroglycerin (NTG) was assessed in the brachial artery using B-mode high resolution ultrasound. CAD patients showed markedly impaired FMD compared to the non-CAD group (5.7±4.8 versus 12.6±6.7%, P<0.0001) and to controls (5.7±4.8 versus 15.7±3.9%, P<0.00001). NTG induced similar degrees of vasodilation in the CAD and non-CAD groups but less vasodilation in the CAD patients compared to controls (12.2±6.3 versus 20.4±6.9%, P<0.01). On univariate analysis, impaired FMD in CAD patients and non-CAD patients was related to the extent of coronary disease (1-, 2- or 3-vessel disease; r=−0.67, P<0.0001), to the maximum percent diameter stenosis in one of the major coronary vessels (r=−0.52, P<0.0001), brachial artery diameter (r=−0.46, P<0.0001) and plasma cholesterol level (r=−0.34, P<0.001). On multiple stepwise regression analysis the extent of coronary disease (r=−0.51, P<0.0001) and the baseline brachial artery diameter (r=−0.37, P<0.0001) were independently associated with FMD in CAD and non-CAD patients. The present findings suggest that the impairment of FMD in the brachial artery, a marker of systemic endothelial function, is closely related to the angiographic extent of CAD.